Ophthalmology

General Dermatology

Questions discussed in this category

How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?

This question is part of a collaboration with RheumMadness and is specifically in reference to: Cost Effectiveness of HCQ Screening.

7 Answers available

For patients with xanthelasma, aside from a lipid panel, do you perform any additional lab workup or send referrals?

2 Answers available

What topical therapies do you most commonly prescribe for rashes near the eyes?

1 Answer available

What recommendations do you provide to patients who develop ocular side effects with Dupixent?

Do you refer them to Ophthalmology? Have you had to switch patients off of Dupixent due to their ocular side effects?

3 Answers available

Papers discussed in this category

Arthritis & rheumatology (Hoboken, N.J.), 2021 Apr 26

American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity.

Ophthalmology, 2016-06

Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

Ophthalmology, 2025 Nov 11

Special AAO Report: Recommendations on Screening for Hydroxychloroquine Retinopathy (2025 Revision).

Related Topics in Ophthalmology